Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

DBV Technologies SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Mar 2015 Reuters Investment Profile 12 $20.00

ValuEngine Industry Report for Medical-biomed/genetics(DBVT)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

20 Mar 2015 ValuEngine, Inc. 10 $49.00

DBV Technologies S.A. (DBV) - Financial Analysis Review

DBV Technologies S.A. (DBV) - Financial Analysis Review Summary DBV Technologies S.A. (DBV) is a biopharmaceutical and ...

17 Mar 2015 GlobalData 38 $125.00

DBV TECHNOLOGIES: ADR - FURTHER SUPPORT FOR VIASKIN PEANUT AT AAAAI

Detailed Phase IIb VIPES data presented recently at AAAAI reaffirm the positive top-line data already reported and highlight ...

06 Mar 2015 Edison Investment Research 7 $10.00

DBV TECHNOLOGIES - ADR - FURTHER SUPPORT FOR VIASKIN PEANUT AT AAAAI

Detailed Phase IIb VIPES data presented recently at AAAAI reaffirm the positive top-line data already reported and highlight ...

06 Mar 2015 Edison Investment Research 7 $10.00

DBV TECHNOLOGIES - FURTHER SUPPORT FOR VIASKIN PEANUT AT AAAAI

Detailed Phase IIb VIPES data presented recently at AAAAI reaffirm the positive top-line data already reported and highlight ...

06 Mar 2015 Edison Investment Research 7 $10.00

Wright Investors Service Comprehensive Report for Dbv Technologies

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

28 Feb 2015 Wright Reports 54 $75.00

DBV TECHNOLOGIES – ADR INITIATION: GOOD VIBES FROM VIPES

The positive VIPES Viaskin Peanut Phase II data impress on both efficacy and safety, reinforcing our $2.4bn peak sales foreca...

18 Nov 2014 Edison Investment Research 12 $10.00

DBV TECHNOLOGIES - GOOD VIBES FROM VIPES

The positive VIPES Viaskin Peanut Phase II data impress on both efficacy and safety, reinforcing our €1.9bn peak sales foreca...

13 Nov 2014 Edison Investment Research 12 $10.00

DBV Technologies SA (DBV) - Financial Analysis Review

DBV Technologies SA (DBV) - Financial Analysis Review Summary DBV Technologies (DBV) is a pharmaceutical and healthcare compa...

03 Nov 2014 GlobalData 39 $125.00